Related Experiment Videos
Progressive multifocal leukoencephalopathy. A cause of visual loss
Archives of Ophthalmology (Chicago, Ill. : 1960)
|April 1, 1977
Summary
Progressive multifocal leukoencephalopathy (PML) caused visual blurring in a leukemia patient. Antiviral treatments like cytarabine may help manage this central nervous system demyelinating disease.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Chronic lymphocytic leukemia (CLL) is a hematologic malignancy.
- Progressive multifocal leukoencephalopathy (PML) is a rare, demyelinating disease of the central nervous system (CNS).
- PML is caused by the JC virus (a papovavirus) reactivating in immunocompromised individuals.
Observation:
- A patient with a five-year history of CLL developed visual blurring.
- The visual disturbance was attributed to occipital lobe lesions.
- These lesions were diagnosed as PML.
Findings:
- PML pathogenesis involves JC virus replication in CNS oligodendrocytes.
- Impaired cell-mediated immunity, common in CLL patients, facilitates viral replication.
- Viral proliferation leads to oligodendrocyte destruction and extensive brain white matter demyelination.
Implications:
- This case highlights PML as a potential neurological complication in long-term CLL patients.
- Early diagnosis and intervention are crucial for managing PML.
- Antiviral therapies, including cytarabine, show potential therapeutic benefit in PML treatment.